Evolutionary Origins of Recurrent Pancreatic Cancer
Marc A Attiyeh,
Jeffrey M. Gerold,
Alvin P. Makohon-Moore,
Johannes G. Reiter,
Craig M. Bielski,
Eileen M. O’Reilly,
Laura D. Wood,
Ralph H. Hruban,
Martin A. Nowak,
Nicholas D Socci,
Barry S. Taylor,
Posted 31 Oct 2019
bioRxiv DOI: 10.1101/811133
Posted 31 Oct 2019
Surgery is the only curative option for Stage I/II pancreatic cancer, nonetheless most patients will recur after surgery and die of their disease. To identify novel opportunities for management of recurrent pancreatic cancer we performed whole exome or targeted sequencing of 10 resected primary cancers and matched intrapancreatic recurrences or distant metastases. We identified that adjuvant or first-line platinum therapy corresponds to an increased mutational burden of recurrent disease. Recurrent disease is enriched for mutations that activate Mapk/Erk and PI3K/AKT signaling and develops from a monophyletic or polyphyletic origin. Treatment induced genetic bottlenecks lead to a modified genetic landscape and subclonal heterogeneity for driver gene alterations in part due to intermetastatic seeding. In one patient what was believed to be recurrent disease was an independent (second) primary tumor. These findings advocate for combination therapies with immunotherapy and routine post-treatment sampling as a component of management of recurrent pancreatic cancer.
- Downloaded 520 times
- Download rankings, all-time:
- Site-wide: 24,533 out of 77,363
- In cancer biology: 762 out of 2,680
- Year to date:
- Site-wide: 19,839 out of 77,363
- Since beginning of last month:
- Site-wide: 34,890 out of 77,363
Downloads over time
Distribution of downloads per paper, site-wide
- 18 Dec 2019: We're pleased to announce PanLingua, a new tool that enables you to search for machine-translated bioRxiv preprints using more than 100 different languages.
- 21 May 2019: PLOS Biology has published a community page about Rxivist.org and its design.
- 10 May 2019: The paper analyzing the Rxivist dataset has been published at eLife.
- 1 Mar 2019: We now have summary statistics about bioRxiv downloads and submissions.
- 8 Feb 2019: Data from Altmetric is now available on the Rxivist details page for every preprint. Look for the "donut" under the download metrics.
- 30 Jan 2019: preLights has featured the Rxivist preprint and written about our findings.
- 22 Jan 2019: Nature just published an article about Rxivist and our data.
- 13 Jan 2019: The Rxivist preprint is live!